Prurigo Nodularis in a Patient With Primary B‐Cell Immunodeficiency Successfully Treated With Low‐Dose Methotrexate: A Case Report
ABSTRACT Prurigo nodularis is a chronic pruritic condition that leads to a vicious itch‐scratch cycle, which can significantly impair quality of life. Low‐dose methotrexate is an effective option for patients with chronic nodular prurigo not responding to topical therapy, offering a favorable safety...
Saved in:
| Main Authors: | Hamad El Hajj, Dima Jeha, Jennifer Abi Younis, Peter Noun, Maya Habre |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.70605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunometabolic reprogramming in the management of prurigo nodularis with methotrexate
by: Viviane Liao, BA, et al.
Published: (2025-09-01) -
Four Cases of Prurigo Nodularis Requiring Nemolizumab due to Persistent Pruritus or Lesions after Dupilumab Treatment
by: Yoshihito Mima, et al.
Published: (2025-06-01) -
Prurigo Nodularis at Ultra-High-Frequency Ultrasound
by: Alessandra Michelucci, et al.
Published: (2025-06-01) -
Taiwanese Dermatological Association consensus for the diagnosis and management of prurigo nodularis
by: Cheng-Che E. Lan, et al.
Published: (2025-01-01) -
Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab
by: Zhang Y, et al.
Published: (2025-06-01)